Filing Details

Accession Number:
0001144204-15-035262
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-03 16:33:29
Reporting Period:
2015-06-01
Filing Date:
2015-06-03
Accepted Time:
2015-06-03 16:33:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1429260 Fortress Biotech Inc. FBIO Pharmaceutical Preparations (2834) 205157386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
941841 Md A Lindsay Rosenwald C/o Fortress Biotech, Inc.
3 Columbus Circle, 15Th Floor
New York NY US 10019
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2015-06-01 785 $1.80 4,792,106 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.001 170,983 Indirect By Capretti Grandi LLC
Common Stock, Par Value $0.001 453,822 Indirect By LAR Family Trusts
Common Stock, Par Value $0.001 742,861 Indirect By Paramount Biosciences
Common Stock, Par Value $0.001 100,000 Indirect By The Lindsay A. Rosenwald Rhode Island Irrevocable Trust U/T/A DTD 8-28-01
Common Stock, Par Value $0.001 80,000 Indirect By The Lindsay A. Rosenwald Alaska Irrevocable Trust U/T/A DTD 8-29-01
Common Stock, Par Value $0.001 720,000 Indirect By The Lindsay A. Rosenwald 2000 Irrevocable Trust U/T/A DTD 5-24-00
Common Stock, Par Value $0.001 100,000 Indirect By The Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust U/T/A DTD 8-29-01
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Options to purchase Common Stock $1.37 2020-10-05 25,000 25,000 Direct
Common Stock Options to purchase Common Stock $6.25 2022-02-10 15,000 15,000 Direct
Common Stock Options to purchase Common Stock $7.42 2023-02-07 15,000 15,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2020-10-05 25,000 25,000 Direct
2022-02-10 15,000 15,000 Direct
2023-02-07 15,000 15,000 Direct
Footnotes
  1. These shares were acquired under the Issuer's 2012 Employee Stock Purchase Plan.
  2. This option is fully vested.
  3. One-third of the shares vested on each of February 10, 2013, 2014 and 2015.
  4. One-third of the shares will vest on each of February 7, 2014, 2015 and 2016.